Therapeutic peptide based on CTL epitope of human melanoma antigen MART-1 can induce CD8~+ T cell response in vitro
- VernacularTitle:MART-1特异性治疗性多肽诱导CD8~+T细胞应答的研究
- Author:
Tongdong SHI
;
Li WANG
;
Zhengcai JIA
;
Wei ZHOU
;
Liyun ZOU
;
- Publication Type:Journal Article
- Keywords:
melanoma;
therapeutic peptide;
epitope;
immunogenicity;
CTL
- From:Journal of Third Military Medical University
2003;0(10):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore how to improve the immunogenicity of short epitope peptides of triggering melanoma MART 1 specific CD8 +T cell responses Methods Therapeutic peptides based on the immunodominant MART 127 35, HIV Tat49 57CCP sequence and a tetanus toxoid universal Th epitope were designed and synthesized The immunological functions were studied in PBMCs from HLA A2 + melanoma patients Results The results demonstrated that the peptides could trigger vigorous MART 1 specific CD8 + CTL activities in vitro The function of peptide containing MART 127 35 and tetanus universal Th epitope was more vigorous than that of MART 127 35 peptide, and the immunogenicty of the peptides with HIV Tat49 57CCP sequence, MART 127 35 and tetanus universal Th epitope was the most vigorous Conclusion Linkage of HIV Tat49 57CCP sequence and a tetanus universal Th epitope could dramatically improve the immunogenictiy of the MART 127 35 epitope peptide
